Archive · 10 Nov 2025
Manipal Hospitals Aims for December IPO Filing with Over $1 Billion Valuation
Manipal Hospitals, a large hospital company partly owned by investors like Temasek, is planning to sell shares to the public for the first time, called an IPO.
They want to do this in December and hope people will value their company at over a trillion rupees, which is a lot of money.
The money they raise will help them buy more hospitals and grow bigger.
They also want to pay off some of the money they owe.
They have many hospitals across India and are one of the biggest healthcare providers in Asia.
Recently, they bought another hospital chain, making them even larger.
Some of their owners might also sell a small portion of their shares to the public as part of the IPO.
The company will make final decisions about the IPO details soon.
Manipal Health Enterprises plans to file its IPO draft prospectus in December.
The company is targeting a valuation between ₹1 trillion and ₹1.2 trillion.
The IPO will include both primary fundraising for the company and a secondary offer for sale.
Manipal Hospitals recently exceeded 12,000 beds after acquiring Sahyadri Hospitals.
The fundraising is intended to support future acquisitions and debt reduction.
- Who
- Manipal Health Enterprises Ltd. (Temasek-backed hospital chain)
- What
- Plans to file for an Initial Public Offering (IPO) with a mix of primary and secondary fundraising, aiming for a valuation over ₹1 trillion.
- When
- Targeting December for IPO filing; final board decisions on timeline and fundraising quantum expected next week.
- Where
- India
- Why
- To raise capital for acquisitions, boost financial war chest, and potentially reduce debt.
Primary Fundraising for Growth
Secondary Fundraising for Shareholder Liquidity
Capital Allocation Strategy
Primary Fundraising for Growth
The company plans to raise substantial primary capital to boost its war chest for potential large acquisitions and to pay down debt.
Secondary Fundraising for Shareholder Liquidity
A portion of the IPO will be an offer for sale (OFS) to meet regulatory requirements for minimum dilution, though it's expected to be a smaller component as few existing investors wish to exit.
Valuation Drivers
Primary Fundraising for Growth
Pitches to investors range around ₹1-1.2 trillion due to the company's significant size and scale achieved in recent years.
Secondary Fundraising for Shareholder Liquidity
The valuation is also influenced by recent transactions and market conditions, with a final decision on the exact valuation to be made by the board.
- Target IPO Filing Date
- December
- Target Valuation
- ₹1 trillion - ₹1.2 trillion ($1 billion+)
- Company Founder
- Ranjan Pai
- Major Investor (Temasek Stake)
- ~59%
- Total Bed Count (Post-Acquisition)
- >12,000
- Consolidated Debt (as of March 31, 2025)
- ~₹5,200 crore
- FY25 Consolidated Revenue
- ₹8,242 crore
- FY25 EBITDA Margin
- 25.8%